A balanced guide for patients and clinicians
-
Chronic pulmonary aspergillosis (CPA)
-
Allergic bronchopulmonary aspergillosis (ABPA) (selected cases)
-
Invasive aspergillosis
-
Azole-resistant or itraconazole-intolerant cases
It is available orally and intravenously and is often used when a stronger or more reliably absorbed azole is required.
1️⃣ What Voriconazole Does
Voriconazole works by blocking fungal ergosterol synthesis (CYP51 inhibition), which disrupts the fungal cell membrane.
Compared with itraconazole:
-
More potent against Aspergillus
-
More predictable oral absorption
-
More central nervous system penetration
It often produces symptom improvement over weeks, though some effects (e.g. visual symptoms) may occur quickly.
2️⃣ How Long Is Treatment?
In CPA
-
Often 6–12 months or longer
-
Sometimes used as second-line or after intolerance to itraconazole
-
Long-term suppressive therapy may be required
In ABPA
-
Used in selected steroid-dependent or refractory cases
In invasive disease
-
Typically several months depending on response and immune status
3️⃣ Why Blood Level Monitoring Is Essential
Voriconazole has non-linear pharmacokinetics.
Small dose changes can cause large blood level shifts.
Two patients on the same dose may have very different levels due to:
-
Liver metabolism (CYP2C19 genetic variation is important)
-
Drug interactions
-
Age
-
Weight
-
Liver function
If Levels Are Too Low
-
Treatment failure
-
Persistent fungal activity
-
Risk of resistance
If Levels Are Too High
-
Liver toxicity
-
Neurological side effects
-
Visual disturbances
-
Increased interaction risk
Typical Target (Trough)
-
Generally 1–5.5 mg/L (lab dependent)
-
Toxicity risk increases >5–6 mg/L
Levels are usually checked:
-
5–7 days after starting
-
After dose adjustments
-
If side effects occur
-
If clinical response is inadequate
4️⃣ Common Side Effects (Often Mild & Reversible)
Visual Disturbances (Very Common but Usually Harmless)
-
Blurred vision
-
Altered colour perception
-
Light sensitivity
-
“Wavy” vision
These typically:
-
Occur within 30–60 minutes of dosing
-
Last less than an hour
-
Reduce over time
Patients should avoid night driving initially until they understand their response.
Photosensitivity
-
Increased sensitivity to sunlight
-
Sunburn risk
-
Long-term risk of skin damage with prolonged therapy
Sun protection is important.
Gastrointestinal
-
Nausea
-
Abdominal discomfort
5️⃣ Less Common but Important Effects
Neurological
-
Headache
-
Vivid dreams
-
Hallucinations (usually at high levels)
-
Confusion (dose-related)
These are generally reversible with dose adjustment.
Liver Abnormalities
Routine liver function monitoring is required.
Most abnormalities are mild and resolve with dose modification.
Cardiac Effects
Voriconazole can prolong the QT interval.
Caution in patients with:
-
Known arrhythmias
-
Electrolyte imbalance
-
Other QT-prolonging drugs
ECG monitoring may be appropriate in higher-risk patients.
Skin Cancer Risk (Long-Term Use)
With prolonged use (especially >1–2 years):
-
Increased risk of skin squamous cell carcinoma
-
Particularly in transplant recipients
Sun protection and dermatology review are advised for long-term therapy.
6️⃣ Food & Drug Advice
-
Avoid grapefruit
-
Avoid St John’s Wort
-
Take tablets at least 1 hour before or after meals (food reduces absorption)
Voriconazole has many CYP-mediated interactions and requires careful medication review.
7️⃣ Comparison With Itraconazole (Simple Overview)
| Feature | Itraconazole | Voriconazole |
|---|---|---|
| Absorption variability | High | More predictable |
| Visual side effects | Rare | Common but mild |
| Photosensitivity | Rare | More common |
| QT prolongation | Minimal | Possible |
| TDM needed | Yes | Yes (essential) |
Balanced Summary for Patients
Voriconazole is a strong antifungal used when more reliable or potent treatment is needed. Most side effects are manageable and reversible, and blood monitoring keeps treatment safe.
Clinician Checklist
-
Confirm indication and prior azole exposure
-
Check baseline LFTs
-
Review ECG if cardiac risk present
-
Assess drug interactions (CYP2C19, 2C9, 3A4)
-
Arrange trough level at day 5–7
-
Counsel regarding visual symptoms and sun protection
Share this post
Latest News posts
ABPA: Allergic Reaction or Fungal Presence in the Lungs?
April 22, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
